References
- Hoeper MM, Bogaard HJ, Condliffe R, Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013 Dec 24; 62( 25 Suppl): D42– 50.
- Gomberg-Maitland M, Glassner-Kolmin C, Watson S, Survival in pulmonary arterial hypertension patients awaiting lung transplantation. J Heart Lung Transplant. 2013 Dec. 32( 12): 1179– 86.
- Benza RL, Miller DP, Frost A, Barst RJ, Krichman AM, McGoon MD. Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry. Transplantation. 2010 Aug 15; 90( 3): 298– 305.
- American Lung Association [Internet]. Chicago: American Lung Association; c2016. Lung Health & Diseases: How serious is COPD; 2013 [cited 2016 Jul 19]. Available from: http://www.lung.org/lung-health-and-diseases/lung-disease-lookup/copd/learn-about-copd/how-serious-is-copd.html?referrer=https://www.google.com/
- Yusen RD, Edwards LB, Kucheryavaya AY, et al.; International Society for Heart and Lung Transplantation. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report–2014; focus theme: retransplantation. J Heart Lung Transplant. 2014 Oct; 33( 10): 1009– 24.
- Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance and management, pulmonary vascular disease: the global perspective. Chest. 2010 Jun; 137( 6 Suppl): 39S– 51S.
-
Hayes
D
Jr , Black SM, Tobias JD, Mansour HM, Whitson BA. Prevalence of pulmonary hypertension and its influence on survival in patients with advanced chronic obstructive pulmonary disease prior to lung transplantation. COPD. 2016; 13( 1): 50– 6. - Singh VK, George MP, Gries CJ. Pulmonary hypertension is associated with increased post-lung transplant mortality risk in patients with chronic obstructive pulmonary disease. J Heart Lung Transplant. 2015 Mar; 34( 3): 424– 9.
- Hamada K, Nagai S, Tanaka S, Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticators in patients with idiopathic pulmonary fibrosis. Chest. 2007 Mar; 131( 3): 650– 6.
- Castria D, Refini RM, Bargagli E, Mezzasalma F, Pierli C, Rottoli P. Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress. Int J Immunopathol Pharmacol. 2012 Jul–Sep; 25( 3): 681– 9.
-
Hayes
D
Jr , Higgins RS, Black SM, Effect of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis after lung transplantation: an analysis of the United Network of Organ Sharing Registry. J Heart Lung Transplant. 2015 Mar; 34( 43): 430– 7. - Zimmermann GS, von Wulffen W, Huppmann P, Hemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors. Respirology. 2014 Jul; 19( 5): 700– 6.
- Idiopathic Pulmonary Fibrosis Clinical Research Network, Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med. 2010 Aug 12; 363( 7): 620– 8.
- Hervé P, Lebrec D, Brenot F, Pulmonary vascular disorders in portal hypertension. Eur Respir J. 1998 May; 11( 5): 1153– 66.
- Plevak D, Krowka M, Rettke S, Dunn W, Southorn P. Successful liver transplantation in patients with mild to moderate pulmonary hypertension. Transplant Proc. 1993 Apr; 25( 2): 1840.
- Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004 May 1; 363( 9419): 1461– 8.
- Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transplant. 2000 Jul; 6( 4): 43– 50.
- Krowka MJ, Miller DP, Barst RJ, Portopulmonary hypertension: a report from the US-based REVEAL Registry. Chest. 2012 Apr; 141( 4): 906– 15.
- Salgia RJ, Goodrich NP, Simpson H, Merion RM, Sharma P. Outcomes of liver transplantation for portopulmonary hypertension in model for end-stage liver disease era. Dig Dis Sci. 2014 Aug; 59( 8): 1976– 82.
- Goldberg DS, Batra S, Sahay S, Kawut SM, Fallon MB. MELD exceptions for portopulmonary hypertension: current policy and future implementation. Am J Transplant. 2014 Sep; 14( 9): 2081– 7.
- Ramasubbu K, Deswal A, Herdejurgen C, Aguilar D, Frost A. A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance. Int J Gen Med. 2010 Oct 5; 3: 279– 86.
- Zlotnick DM, Axelrod DA, Chobanian MC, Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction. Nephrol Dial Transplant. 2010 Sep; 25( 9): 3090– 6.
- Naim I, Krowka M, Griffin M, Hickson L, Stegall M, Cosio F. Pulmonary Hypertension Is Associated With Reduced Patient Survival After Kidney Transplantation. Transplantation. 2008 Nov 27; 86( 10): 1384– 8.
- Bal Z, Sezer S, Uyar ME, Pulmonary hypertension is closely related to arterial stiffness in renal transplant patients. Transplant Proc. 2015 May; 47( 4): 1186– 9.
- Stallworthy EJ, Pilmore HL, Webster MW, Do echocardiographic parameters predict mortality in patients with end-stage renal disease? Transplantation. 2013; 95: 1225– 32.
- Butler J, Stankewicz MA, Wu J, Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant. 2005 Feb; 24( 2): 170– 7.
DOI: https://doi.org/10.14797/mdcj-12-4s1-10 | Journal eISSN: 1947-6108
Language: English
Page range: 10 - 13
Published on: Dec 1, 2016
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2016 Adaani E. Frost, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.